bullish

3SBio Inc

3SBio (1530 HK) Plans to Spin-Off and List Mandi in HK - Thoughts on The "Implied" IPO Price

493 Views23 Nov 2025 08:55
​3SBio to spin-off Mandi on Hong Kong Stock Exchange,with Minoxidil becoming the main driver for revenue growth.Valuation range estimated at RMB31-40 billion based on projected revenue of RMB1.5-1.6bn
What is covered in the Full Insight:
  • Introduction to the Spin-Off
  • Mandi's Core Business and Growth Drivers
  • Market Position and Competition Analysis
  • Revenue Projections and Valuation
  • Risks and Considerations
Boomeranged on Tue, 25 Nov 2025 08:58
3SBio plans to spin-off and list Mandi on the Hong Kong Stock Exchange, which means investors have the opportunity to become a direct shareholder of Mandi. Given Minoxidil's strong growth momentum, Mandi's 2025 revenue growth would be 15%-20% YoY, with projected revenue of RMB1.538-1.604 billion. Due to leadership position, valuation range for Mandi could be RMB31-40 billion based on P/S of 20-25x
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
chart-bar
x